DONATE

Sightsavers awarded grant to fight neglected tropical diseases in Guinea-Bissau

December 2022
A young boy drinks water after receiving preventative medication for lymphatic filariasis in Guinea-Bissau.
Children and adults will receive medication to protect them from four diseases. © Ruth McDowall/Sightsavers

The Astellas Global Health Foundation has awarded Sightsavers a grant of US$536,700 to help treat four neglected tropical diseases in Guinea-Bissau.

The grant will enable Sightsavers to distribute one million treatments to combat river blindness, lymphatic filariasis, schistosomiasis and intestinal worms in six endemic areas of the country.

More than 1.2 million people are at risk of infection in Guinea-Bissau and the treatments will help reduce the morbidity, mortality and disability associated with the debilitating diseases. Once they’re protected through medication, children can continue their education and adults can earn a living and support their families.

The Astellas Global Health Foundation is an international philanthropic organisation that focuses on improving access to health care, building community resilience and providing disaster support around the world. Sightsavers is one of five organisations that will benefit from the foundation’s latest grants, which will total US$3.9 million.

Astellas logo

Read all our latest news stories

News from Sightsavers
12-year-old Fiza smiles after receiving glasses through an eye test at her school.

Sightsavers partners with AI tech company to improve rural eye care

OptikosPrime’s innovative app aims to help people living in low and middle income countries access vision testing via smartphone.

January 2025
President Jimmy Carter smiles, with the US flag behind him.

Sightsavers pays tribute to President Jimmy Carter

The 39th president of the United States died on 29 December, aged 100.

January 2025

What we achieved in 2024

Sightsavers did incredible things in 2024, but we couldn’t have done it without our supporters, partners and staff. Learn what we’ve achieved together this year.

December 2024